Patient Protection and Affordable Care Act (PPACA); Emerging Infections Program (EIP); Enhancing Epidemiology and Laboratory Capacity (U01)

The summary for the Patient Protection and Affordable Care Act (PPACA); Emerging Infections Program (EIP); Enhancing Epidemiology and Laboratory Capacity (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
Patient Protection and Affordable Care Act (PPACA); Emerging Infections Program (EIP); Enhancing Epidemiology and Laboratory Capacity (U01): The purpose of this EIP-ACA FOA is to support state and local health departments' surveillance infrastructure through enhancement of the epidemiology and laboratory capacity of the existing EIP network. Over the past 15 years, the EIP network has proved to be a national resource for conducting active, population-based surveillance and special studies for invasive bacterial diseases, foodborne pathogens, healthcare associated infections (HAIs), influenza, and many other infectious diseases. The network has been instrumental in measuring the impact of the 7-valent pneumococcal conjugate vaccine, informing and evaluating treatment guidelines for Group B Streptococcus, estimating the burden of foodborne illness, documenting the emergence of community-associated methicillin-resistant Staphylococcus aureus, and monitoring the safety of the 2009 H1N1 vaccine as part of the influenza vaccine safety network ( EIP activities and special studies frequently shift according to priorities for infectious disease emergency response and program areas. The flexibility of the network is ideal for implementing activities in response to rapidly changing scientific priorities. These investments in the basic infrastructure support multiple activities at each site and are critical for a comprehensive, efficient, and coordinated approach to general program management from which all activities benefit. EIP sites may conduct up to 65 different surveillance and research activities related to infectious diseases during the course of a year. These activities require investments in personnel time to implement or modify, including building collaborative relationships with local hospitals, laboratories, and healthcare providers; submitting applications to multiple institutional review boards for dozens of studies; hiring, supervising and training staff; facilitating information exchange between CDC, local epidemiologists and laboratories; and actively participating in numerous conference calls, conferences, and meetings with CDC investigators. Given the significant activities of EIP sites, this FOA provides an opportunity to enhance support for the basic infrastructure of the EIP network.
Federal Grant Title: Patient Protection and Affordable Care Act (PPACA); Emerging Infections Program (EIP); Enhancing Epidemiology and Laboratory Capacity (U01)
Federal Agency Name: Centers for Disease Control and Prevention
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CI-10-003
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.521
CFDA Descriptions: The Affordable Care Act: Building Epidemiology, Laboratory, and Health Information Systems Capacity in the Epidemiology
Current Application Deadline: Aug 27, 2010
Original Application Deadline: Aug 27, 2010
Posted Date: Aug 17, 2010
Creation Date: Aug 17, 2010
Archive Date: Sep 26, 2010
Total Program Funding: $4,500,000
Maximum Federal Grant Award: $650,000
Minimum Federal Grant Award: $0
Expected Number of Awards: 10
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Eligible Institutions You may submit an application(s) if your organization has any of the following characteristics: Eligibility for these awards is limited to current grantees under the EIP cooperative agreement program which are the health departments of California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Tennessee, and Oregon or their Bona Fide Agents. These 10 grantees are currently funded under EIP Funding Opportunity Announcement numbers CI02-174 (NM) and CI05-026 (CA, CO, CT, GA, MD, MN, NM, NY, TN, OR). Eligibility is limited to current EIP grantees because this ACA activity builds upon existing EIP infrastructure, capacities, and activities. Along with assuring adequate scientific and technical resources, using the existing EIP network will also allow these resources to be implemented efficiently and effectively to support epidemiology and laboratory capacity in the nation's public health system and inform prevention efforts to improve the quality and reduce the cost of healthcare, consistent with the intention of ACA.
Grant Announcement Contact
Centers for Disease Control and Prevention Procurement and Grants Office TIMS Phone 770-488-2700 []
Similar Government Grants
PPHF 2016: Epidemiology and Laboratory Capacity Program - Emerging Infections Programs - F...
PPHF 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) - Building an...
PPHF 2012-Epidemiology and Laboratory Capacity (ELC/EIP)-Emerging Infections Programs (EIP...
PPHF 2012 - ELC Building and Strengthening Epidemiology, Laboratory and Health Information...
Patient Protection and Affordable Care Act (ACA), Emerging Infections Programs (EIP), Enha...
Opportunity CDC-RFA-CI10-1012
Patient Protection and Affordable Care Act Epidemiology and Laboratory Capacity for Infect...
More Grants from the Centers for Disease Control and Prevention
Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...
Strengthening Ebola rapid detection and response capacity through community based surveill...
test2 is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2021